Analysts’ Viewpoint
Growth in prevalence of cardiovascular diseases, increase in healthcare expenditure, and rise in awareness about the benefits of bioabsorbable stents are some of the key factors boosting the global bioabsorbable stents market scope. Additionally, surge in adoption of bioabsorbable stents among healthcare professionals as well as patients is positively impacting market statistics. Increase in demand for minimally invasive procedures, particularly among the elderly population, is further contributing to market progress.
Various companies are investing in research & development activities to introduce advanced and innovative bioabsorbable stents, which offer improved clinical outcomes and enhanced patient comfort, in order to increase their market share.
Bioabsorbable stents are medical devices that are used to treat conditions such as heart diseases. They are inserted into a blocked or narrowed blood vessel to keep it open and improve blood flow. Unlike traditional metallic stents, which remain in the body permanently, bioabsorbable stents are designed to dissolve or disintegrate over time.
Bioabsorbable polymer-based stents and bioabsorbable metallic stents are the two major types of bioabsorbable stents. Bioabsorbable stents are typically made of biodegradable materials, such as polylactic acid or polyglycolic acid, which are naturally absorbed by the body. This allows the treated vessel to return to its normal state once the stent has completely dissolved.
Bioabsorbable stent is a relatively new technology and more research is needed to determine its long-term safety and efficacy compared to traditional metallic stent. However, the results of early clinical trials have been promising.
Demand for bioabsorbable stents is rising across the globe, as these stents are considered safe and non-invasive alternatives over traditional methods. Heart diseases are becoming increasingly common. This rise in prevalence of cardiovascular diseases is driving the demand for bioabsorbable stents. Bioabsorbable stents are gaining popularity across the globe, led by their ability to provide real-time monitoring, improved accuracy, and reduced invasiveness.
According to the World Health Organization (WHO), cardiovascular disease is the leading cause of death globally. As per the WHO, around 17.9 million people died from cardiovascular diseases in 2019, representing 32.0% deaths globally. Furthermore, 85.0% of deaths occurred due to strokes and heart attacks.
Bioabsorbable stents possess several advantages over traditional metallic stents, including improved healing and restoration of vessel function, reduced risk of restenosis, and lower need for long-term antiplatelet therapy. These benefits have led to an increase in interest in bioabsorbable stents. Extensive research is being conducted to further understand the usage and benefits of these stents.
Advancements in technology and materials used in the production of bioabsorbable stents is also fueling market dynamics. Furthermore, rise in awareness about the benefits of bioabsorbable stents is likely to boost market growth during the forecast period.
In terms of biomaterial, the industry has been classified into bioabsorbable polymer-based stents and bioabsorbable metallic stents. The bioabsorbable polymer-based stents segment is projected to account for major share during the forecast period.
Bioabsorbable polymer-based stents are medical devices that are used to open and maintain the lumen of blood vessels, particularly coronary arteries. These stents are designed to dissolve over time, typically within one to two years, and are made of biodegradable polymers such as polylactic acid or polyglycolic acid.
Bioabsorbable polymer stents do not leave a permanent implant in the body, thus reducing the risk of long-term complications such as restenosis or stent thrombosis. This is one of the key advantages of these stents.
According to the latest bioabsorbable stents market analysis, the coronary artery disease application segment held significant share in 2022.
The function of the coronary artery is to supply blood to the heart. In coronary artery disease, (CAD), coronary arteries become narrow or blocked due to the accumulation of plaque made up of fat, cholesterol, and other substances. This buildup can lead to chest pain (angina), shortness of breath, heart attack, and other issues. Bioabsorbable stents are increasingly beneficial in such conditions.
In terms of end-user, the global bioabsorbable stents market has been classified into hospitals, cardiac centers, and ambulatory surgical centers. The hospitals end-user segment dominated the global landscape in 2022. However, ambulatory surgical centers is likely to be the fastest-growing segment during the forecast period.
North America accounted for major share of the global bioabsorbable stents market in 2022. The bioabsorbable stents industry is expanding at a rapid pace in the region.
According to the Center for Disease Control and Prevention, (CDC), one person dies every 34 seconds due to cardiovascular diseases in the U.S. Hence, rise in incidence of cardiovascular diseases is likely to fuel development of the bioabsorbable stents market in the region during the forecast period.
Bioabsorbable stents market growth appears promising in Asia Pacific. As per the American Stroke Association, cardiovascular diseases are the leading causes of mortality in India. According to the American College of Cardiology Foundation, cardiovascular diseases were the leading causes of death (10.8 million) in Asia Pacific in 2019, representing nearly 35.0% of the total deaths in the region. Growth in awareness about the benefits of bioabsorbable stents is fueling market dynamics in Asia Pacific.
The global bioabsorbable stents market is fragmented, with the presence of a large number of local as well as international players. Expansion of product portfolio and mergers & acquisitions are key strategies adopted by prominent players.
Leading players in the global bioabsorbable stents market are Arterius Limited, B. Braun Melsungen AG, Boston Scientific Corporation, Kyoto Medical Planning Co. Ltd., Reva Medical, Microport Scientific Corporation, Amaranth Medical, Terumo Corporation, Arterial Remodeling Technologies, Biotronik SE & Co. KG, and Elixir Medical Corporation.
Key players have been profiled in the bioabsorbable stents market research report based on parameters such as financial overview, company overview, product portfolio, business segments, recent developments, and business strategies.
Attribute |
Detail |
Market Size Value in 2022 |
US$ 375.5 Mn |
Market Forecast Value in 2031 |
US$ 560.1 Mn |
Growth Rate (CAGR) |
6.4% |
Forecast Period |
2023–2031 |
Historical Data Available for |
2017–2021 |
Quantitative Units |
US$ Mn for Value |
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
It was valued at US$ 375.5 Mn in 2022.
It is projected to reach more than US$ 560.1 Mn by 2031.
The CAGR is anticipated to be 6.4% from 2023 to 2031.
Growth in awareness about benefits of bioabsorbable stents and increase in incidence of cardiovascular diseases.
North America is expected to account for the largest share during the forecast period.
Amaranth Medical, Arterial Remodeling Technologies, Arterius Limited, B. Braun Melsungen AG, Biotronik SE & Co. KG, Boston Scientific Corporation, Elixir Medical Corporation, Kyoto Medical Planning Co. Ltd., Microport Scientific Corporation, Reva Medical, and Terumo Corporation.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Bioabsorbable Stents Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Bioabsorbable Stents Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Technological Advancements
5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short / Mid / Long Term Impact)
6. Global Bioabsorbable Stents Market Analysis and Forecast, By Biomaterial
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Biomaterial, 2017-2031
6.3.1. Bioabsorbable Polymer-based Stents
6.3.2. Bioabsorbable Metallic Stents
6.4. Market Attractiveness By Biomaterial
7. Global Bioabsorbable Stents Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Application, 2017-2031
7.3.1. Coronary Artery Disease
7.3.2. Peripheral Artery Disease
7.4. Market Attractiveness By Application
8. Global Bioabsorbable Stents Market Analysis and Forecast, By Absorption Rate
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Absorption Rate, 2017-2031
8.3.1. Slow Absorption Rate
8.3.2. Fast Absorption Rate
8.4. Market Attractiveness By Absorption Rate
9. Global Bioabsorbable Stents Market Analysis and Forecast, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Cardiac Centers
9.3.3. Ambulatory Surgical Stent
9.4. Market Attractiveness By End-user
10. Global Bioabsorbable Stents Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness By Country/Region
11. North America Bioabsorbable Stents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Biomaterial, 2017-2031
11.2.1. Bioabsorbable Polymer-based Stents
11.2.2. Bioabsorbable Metallic Stents
11.3. Market Value Forecast By Application, 2017-2031
11.3.1. Coronary Artery Disease
11.3.2. Peripheral Artery Disease
11.4. Market Value Forecast By Absorption Rate, 2017-2031
11.4.1. Slow Absorption Rate
11.4.2. Fast Absorption Rate
11.5. Market Value Forecast By End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Cardiac Centers
11.5.3. Ambulatory Surgical Stent
11.6. Market Value Forecast By Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Biomaterial
11.7.2. By Application
11.7.3. By Absorption Rate
11.7.4. By End-user
11.7.5. By Country
12. Europe Bioabsorbable Stents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Biomaterial, 2017-2031
12.2.1. Bioabsorbable Polymer-based Stents
12.2.2. Bioabsorbable Metallic Stents
12.3. Market Value Forecast By Application, 2017-2031
12.3.1. Coronary Artery Disease
12.3.2. Peripheral Artery Disease
12.4. Market Value Forecast By Absorption Rate, 2017-2031
12.4.1. Slow Absorption Rate
12.4.2. Fast Absorption Rate
12.5. Market Value Forecast By End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Cardiac Centers
12.5.3. Ambulatory Surgical Stent
12.6. Market Value Forecast By Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Biomaterial
12.7.2. By Application
12.7.3. By Absorption Rate
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Bioabsorbable Stents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Biomaterial, 2017-2031
13.2.1. Bioabsorbable Polymer-based Stents
13.2.2. Bioabsorbable Metallic Stents
13.3. Market Value Forecast By Application, 2017-2031
13.3.1. Coronary Artery Disease
13.3.2. Peripheral Artery Disease
13.4. Market Value Forecast By Absorption Rate, 2017-2031
13.4.1. Slow Absorption Rate
13.4.2. Fast Absorption Rate
13.5. Market Value Forecast By End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Cardiac Centers
13.5.3. Ambulatory Surgical Stent
13.6. Market Value Forecast By Country/Sub-region, 2017-2031
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Biomaterial
13.7.2. By Application
13.7.3. By Absorption Rate
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Bioabsorbable Stents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast By Biomaterial, 2017-2031
14.2.1. Bioabsorbable Polymer-based Stents
14.2.2. Bioabsorbable Metallic Stents
14.3. Market Value Forecast By Application, 2017-2031
14.3.1. Coronary Artery Disease
14.3.2. Peripheral Artery Disease
14.4. Market Value Forecast By Absorption Rate, 2017-2031
14.4.1. Slow Absorption Rate
14.4.2. Fast Absorption Rate
14.5. Market Value Forecast By End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Cardiac Centers
14.5.3. Ambulatory Surgical Stent
14.6. Market Value Forecast By Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Biomaterial
14.7.2. By Application
14.7.3. By Absorption Rate
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Bioabsorbable Stents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast By Biomaterial, 2017-2031
15.2.1. Bioabsorbable Polymer-based Stents
15.2.2. Bioabsorbable Metallic Stents
15.3. Market Value Forecast By Application, 2017-2031
15.3.1. Coronary Artery Disease
15.3.2. Peripheral Artery Disease
15.4. Market Value Forecast By Absorption Rate, 2017-2031
15.4.1. Slow Absorption Rate
15.4.2. Fast Absorption Rate
15.5. Market Value Forecast By End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Cardiac Centers
15.5.3. Ambulatory Surgical Stent
15.6. Market Value Forecast By Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Biomaterial
15.7.2. By Application
15.7.3. By Absorption Rate
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Market Share/Ranking Analysis By Company (2022)
16.3. Company Profiles
16.3.1. Amaranth Medical
16.3.1.1. Company Overview
16.3.1.2. Biomaterial Portfolio
16.3.1.3. SWOT Analysis
16.3.1.4. Strategic Overview
16.3.2. Arterial Remodeling Technologies
16.3.2.1. Company Overview
16.3.2.2. Biomaterial Portfolio
16.3.2.3. SWOT Analysis
16.3.2.4. Strategic Overview
16.3.3. Arterius Limited
16.3.3.1. Company Overview
16.3.3.2. Biomaterial Portfolio
16.3.3.3. SWOT Analysis
16.3.3.4. Strategic Overview
16.3.4. B. Braun Melsungen AG
16.3.4.1. Company Overview
16.3.4.2. Biomaterial Portfolio
16.3.4.3. SWOT Analysis
16.3.4.4. Strategic Overview
16.3.5. Biotronik SE & Co. KG
16.3.5.1. Company Overview
16.3.5.2. Biomaterial Portfolio
16.3.5.3. SWOT Analysis
16.3.5.4. Strategic Overview
16.3.6. Boston Scientific Corporation
16.3.6.1. Company Overview
16.3.6.2. Biomaterial Portfolio
16.3.6.3. SWOT Analysis
16.3.6.4. Strategic Overview
16.3.7. Elixir Medical Corporation
16.3.7.1. Company Overview
16.3.7.2. Biomaterial Portfolio
16.3.7.3. SWOT Analysis
16.3.7.4. Strategic Overview
16.3.8. Kyoto Medical Planning Co. Ltd.
16.3.8.1. Company Overview
16.3.8.2. Biomaterial Portfolio
16.3.8.3. SWOT Analysis
16.3.8.4. Strategic Overview
16.3.9. Microport Scientific Corporation
16.3.9.1. Company Overview
16.3.9.2. Biomaterial Portfolio
16.3.9.3. SWOT Analysis
16.3.9.4. Strategic Overview
16.3.10. Reva Medical
16.3.10.1. Company Overview
16.3.10.2. Biomaterial Portfolio
16.3.10.3. SWOT Analysis
16.3.10.4. Strategic Overview
16.3.11. Terumo Corporation
16.3.11.1. Company Overview
16.3.11.2. Biomaterial Portfolio
16.3.11.3. SWOT Analysis
16.3.11.4. Strategic Overview
List of Tables
Table 01: Global Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Biomaterial, 2017‒2031
Table 02: Global Bioabsorbable Stents Market Value (US$ Mn) Forecast, by 2017‒2031, by Application
Table 03: Global Bioabsorbable Stents Market Value (US$ Mn) Forecast, by 2017‒2031, by Absorption Rate
Table 04: Global Bioabsorbable Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Biomaterial, 2017‒2031
Table 08: North America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 09: North America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Absorption Rate, 2017‒2031
Table 10: North America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031
Table 12: Europe Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Biomaterial, 2017‒2031
Table 13: Europe Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 14: Europe Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Absorption Rate, 2017‒2031
Table 15: Europe Bioabsorbable Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Biomaterial, 2017‒2031
Table 18: Asia Pacific Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 19: Asia Pacific Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Absorption Rate, 2017‒2031
Table 20: Asia Pacific Bioabsorbable Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Latin America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Biomaterial, 2017‒2031
Table 23: Latin America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 24: Latin America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Absorption Rate, 2017‒2031
Table 25: Latin America Bioabsorbable Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 26: Middle East & Africa Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Biomaterial, 2017‒2031
Table 28: Middle East & Africa Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 29: Middle East & Africa Bioabsorbable Stents Market Value (US$ Mn) Forecast, by Absorption Rate, 2017‒2031
Table 30: Middle East & Africa Bioabsorbable Stents Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Bioabsorbable Stents Market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Bioabsorbable Stents Market Value Share, by Biomaterial, 2022
Figure 03: Global Bioabsorbable Stents Market Value Share, by Application, 2022
Figure 04: Global Bioabsorbable Stents Market Value Share, by Absorption Rate, 2022
Figure 05: Global Bioabsorbable Stents Market Value Share, by End-user, 2022
Figure 06: Global Bioabsorbable Stents Market Value Share Analysis, by Biomaterial, 2022 and 2031
Figure 07: Global Bioabsorbable Stents Market Attractiveness Analysis, by Biomaterial, 2023-2031
Figure 08: Global Bioabsorbable Stents Market Value Share Analysis, by Application, 2022 and 2031
Figure 09: Global Bioabsorbable Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 10: Global Bioabsorbable Stents Market Value Share Analysis, by Absorption Rate, 2022 and 2031
Figure 11: Global Bioabsorbable Stents Market Attractiveness Analysis, by Absorption Rate, 2023-2031
Figure 12: Global Bioabsorbable Stents Market Value Share Analysis, by End-user, 2022 and 2031
Figure 13: Global Bioabsorbable Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 14: Global Bioabsorbable Stents Market Value Share Analysis, by Region, 2022 and 2031
Figure 15: Global Bioabsorbable Stents Market Attractiveness Analysis, by Region, 2023-2031
Figure 16: North America Bioabsorbable Stents Market Value (US$ Mn) Forecast, 2017–2031
Figure 17: North America Bioabsorbable Stents Market Value Share Analysis, by Country, 2022 and 2031
Figure 18: North America Bioabsorbable Stents Market Attractiveness Analysis, by Country, 2023-2031
Figure 19: North America Bioabsorbable Stents Market Value Share Analysis, by Biomaterial, 2022 and 2031
Figure 20: North America Bioabsorbable Stents Market Attractiveness Analysis, by Biomaterial, 2023-2031
Figure 21: North America Bioabsorbable Stents Market Value Share Analysis, by Application, 2022 and 2031
Figure 22: North America Bioabsorbable Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 23: North America Bioabsorbable Stents Market Value Share Analysis, by Absorption Rate, 2022 and 2031
Figure 24: North America Bioabsorbable Stents Market Attractiveness Analysis, by Absorption Rate, 2023-2031
Figure 25: North America Bioabsorbable Stents Market Value Share Analysis, by End-user, 2022 and 2031
Figure 26: North America Bioabsorbable Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 27: Europe Bioabsorbable Stents Market Value (US$ Mn) Forecast, 2017–2031
Figure 28: Europe Bioabsorbable Stents Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 29: Europe Bioabsorbable Stents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 30: Europe Bioabsorbable Stents Market Value Share Analysis, by Biomaterial, 2022 and 2031
Figure 31: Europe Bioabsorbable Stents Market Attractiveness Analysis, by Biomaterial, 2023-2031
Figure 32: Europe Bioabsorbable Stents Market Value Share Analysis, by Application, 2022 and 2031
Figure 33: Europe Bioabsorbable Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 34: Europe Bioabsorbable Stents Market Value Share Analysis, by Absorption Rate, 2022 and 2031
Figure 35: Europe Bioabsorbable Stents Market Attractiveness Analysis, by Absorption Rate, 2023-2031
Figure 36: Europe Bioabsorbable Stents Market Value Share Analysis, by End-user, 2022 and 2031
Figure 37: Europe Bioabsorbable Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 38: Asia Pacific Bioabsorbable Stents Market Value (US$ Mn) Forecast, 2017–2031
Figure 39: Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Country/Sub-region, 2022 and 2031
Figure 40: Asia Pacific Bioabsorbable Stents Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
Figure 41: Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Biomaterial, 2022 and 2031
Figure 42: Asia Pacific Bioabsorbable Stents Market Attractiveness Analysis, by Biomaterial, 2023-2031
Figure 43: Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Application, 2022 and 2031
Figure 44: Asia Pacific Bioabsorbable Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 45: Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by Absorption Rate, 2022 and 2031
Figure 46: Asia Pacific Bioabsorbable Stents Market Attractiveness Analysis, by Absorption Rate, 2023-2031
Figure 47: Asia Pacific Bioabsorbable Stents Market Value Share Analysis, by End-user, 2022 and 2031
Figure 48: Asia Pacific Bioabsorbable Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 49: Latin America Bioabsorbable Stents Market Value (US$ Mn) Forecast, 2017–2031
Figure 50: Latin America Bioabsorbable Stents Market Value Share Analysis, by Country/Sub-Region, 2022 and 2031
Figure 51: Latin America Bioabsorbable Stents Market Attractiveness Analysis, by Country/Sub-Region, 2022-2031
Figure 52: Latin America Bioabsorbable Stents Market Value Share Analysis, by Biomaterial, 2022 and 2031
Figure 53: Latin America Bioabsorbable Stents Market Attractiveness Analysis, by Biomaterial, 2023-2031
Figure 54: Latin America Bioabsorbable Stents Market Value Share Analysis, by Application, 2022 and 2031
Figure 55: Latin America Bioabsorbable Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 56: Latin America Bioabsorbable Stents Market Value Share Analysis, by Absorption Rate, 2022 and 2031
Figure 57: Latin America Bioabsorbable Stents Market Attractiveness Analysis, by Absorption Rate, 2023-2031
Figure 58: Latin America Bioabsorbable Stents Market Value Share Analysis, by End-user, 2022 and 2031
Figure 59: Latin America Bioabsorbable Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 60: Middle East & Africa Bioabsorbable Stents Market Value (US$ Mn) Forecast, 2017–2031
Figure 61: Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Country/Sub-Region, 2022 and 2031
Figure 62: Middle East & Africa Bioabsorbable Stents Market Attractiveness Analysis, by Country/Sub-Region, 2022-2031
Figure 63: Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Biomaterial, 2022 and 2031
Figure 64: Middle East & Africa Bioabsorbable Stents Market Attractiveness Analysis, by Biomaterial, 2023-2031
Figure 65: Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Application, 2022 and 2031
Figure 66: Middle East & Africa Bioabsorbable Stents Market Attractiveness Analysis, by Application, 2023-2031
Figure 67: Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by Absorption Rate, 2022 and 2031
Figure 68: Middle East & Africa Bioabsorbable Stents Market Attractiveness Analysis, by Absorption Rate, 2023-2031
Figure 69: Middle East & Africa Bioabsorbable Stents Market Value Share Analysis, by End-user, 2022 and 2031
Figure 70: Middle East & Africa Bioabsorbable Stents Market Attractiveness Analysis, by End-user, 2023-2031
Figure 71: Company Share Analysis, 2022